ici 204,219 has been researched along with Constriction, Pathological in 1 studies
zafirlukast: a leukotriene D4 receptor antagonist
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dahlén, B | 1 |
Roquet, A | 1 |
Inman, MD | 1 |
Karlsson, O | 1 |
Naya, I | 1 |
Anstrén, G | 1 |
O'Byrne, PM | 1 |
Dahlén, SE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Randomized Controlled Trial of Marine Lipid Fraction PCSO-524™ on Airway Inflammation and Hyperpnea-Induced Bronchoconstriction in Asthma[NCT01504646] | 20 participants (Actual) | Interventional | 2012-01-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for ici 204,219 and Constriction, Pathological
Article | Year |
---|---|
Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction.
Topics: Bronchial Diseases; Constriction, Pathologic; Cross-Over Studies; Double-Blind Method; Drug Therapy, | 2002 |